MENQUADFI
Biological
SANOFI PASTEUR INC.
Total Payments
$433,193
Transactions
14,761
Doctors
11,107
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $52,329 | 1,989 | 1,896 |
| 2023 | $142,011 | 5,272 | 4,706 |
| 2022 | $125,098 | 4,244 | 3,919 |
| 2021 | $54,501 | 3,025 | 2,836 |
| 2020 | $59,253 | 231 | 223 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $289,306 | 14,686 | 66.8% |
| Unspecified | $51,860 | 15 | 12.0% |
| Consulting Fee | $46,670 | 31 | 10.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $44,367 | 24 | 10.2% |
| Travel and Lodging | $989.48 | 5 | 0.2% |
Payments by Type
General
$381,333
14,746 transactions
Research
$51,860
15 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults 56 Years and Older | SANOFI PASTEUR INC. | $11,220 | 3 |
| Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years | SANOFI PASTEUR INC. | $11,220 | 3 |
| Immunogenicity and Safety of a Booster Dose of an Investigational Quadrivalent Meningococcal Conjugate Vaccine | SANOFI PASTEUR INC. | $9,972 | 4 |
| Immune Lot Consistency, Immunogenicity, and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine | SANOFI PASTEUR INC. | $7,480 | 2 |
| Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents | SANOFI PASTEUR INC. | $7,480 | 2 |
| Study of a Quadrivalent Meningococcal Conjugate Vaccine in Subjects Aged 56 and Older | SANOFI PASTEUR INC. | $4,488 | 1 |
Top Doctors Receiving Payments for MENQUADFI
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Infectious Disease | Omaha, NE | $12,077 | 12 |
| , M.D | Family Medicine | Salt Lake City, UT | $9,973 | 3 |
| , MD | Pediatrics | Bardstown, KY | $9,973 | 3 |
| , MD | Internal Medicine | Ventura, CA | $8,593 | 3 |
| , MD | Pediatric Infectious Diseases | Carmel, IN | $7,923 | 6 |
| , M.D | Internal Medicine | Metairie, LA | $6,233 | 2 |
| , M.D | Pediatrics | Nicholasville, KY | $6,233 | 2 |
| , M.D | Infectious Disease | Derry, NH | $5,524 | 3 |
| , MD | Infectious Disease | Orlando, FL | $5,524 | 3 |
| , APRN,BC | Family | Phoenix, AZ | $5,386 | 4 |
| , MD | Family Medicine | Buffalo, NY | $4,621 | 2 |
| , M.D | Family Medicine | West Jordan, UT | $4,488 | 1 |
| John Russell | Family Medicine | Jenkintown, PA | $4,061 | 3 |
| , M.D | Pediatric Infectious Diseases | Corpus Christi, TX | $4,005 | 3 |
| , MD | Family Medicine | Salt Lake City, UT | $3,740 | 1 |
| , M.D | Internal Medicine | San Diego, CA | $3,740 | 1 |
| , M.D., F.A.A.F.P | Family Medicine | Dallas, TX | $3,740 | 1 |
| , D.O | Family Medicine | Wichita, KS | $3,740 | 1 |
| , ARNP | Family | Amherst, NH | $3,736 | 3 |
| , MD | Dermatology | Rochester, NY | $3,717 | 1 |
| , MD | Internal Medicine | Meriden, CT | $3,059 | 2 |
| , MD | Family Medicine | Indianapolis, IN | $2,818 | 2 |
| , M.D | Pediatrics | Kansas City, MO | $2,136 | 1 |
| , M.D | Infectious Disease | Dallas, TX | $1,996 | 1 |
| , M.D., | Pediatric Allergy/Immunology | Miami Lakes, FL | $1,884 | 1 |
Ad
Manufacturing Companies
- SANOFI PASTEUR INC. $433,193
Product Information
- Type Biological
- Total Payments $433,193
- Total Doctors 11,107
- Transactions 14,761
About MENQUADFI
MENQUADFI is a biological associated with $433,193 in payments to 11,107 healthcare providers, recorded across 14,761 transactions in the CMS Open Payments database. The primary manufacturer is SANOFI PASTEUR INC..
Payment data is available from 2020 to 2024. In 2024, $52,329 was paid across 1,989 transactions to 1,896 doctors.
The most common payment nature for MENQUADFI is "Food and Beverage" ($289,306, 66.8% of total).
MENQUADFI is associated with 6 research studies, including "Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults 56 Years and Older" ($11,220).